🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Spain / NCT06310434
Enrolling by invitation Observational

Analysis of COMPASsion and Humanisation of Adolescents Facing the End-of-life Processes.

NCT06310434 · tracked via the Priya Life Science Spain tracker
Sponsor
Instituto de Salud Carlos III
Phase
Observational
Started
2024-09-01
Last updated
2025-06-19

Condition(s) studied

CompassionDeath AnxietyAdolescent Behavior

Investigational drug(s) / intervention(s)

questionnaireDiscussion groupReflective diary

questionnaire: COOL Scale and DAS

Discussion group: Through discussion groups with students in secondary schools and university separately, a compassionate plan will be designed

Reflective diary: Students can modify the interventions adapting them to their requirements to get the compassion needed for those in need.

Study summary

The investigators want to work on compassion, understood as the recognition of the suffering of others that motivates us to try to alleviate it. The goal of this Multicenter project, with a mixed sequential transformative methodology, is to analyze the impact of a participatory process of awareness and reflection on compassion, in the face of end-of-life processes, in adolescents aged 12-23 years in 6 Spanish provinces, and to understand how the participatory process can transform and improve their compassion.

As the adolescents must be the protagonists of change, the study will be conducted with students enrolled in one public secondary school and in one degree in a public University, that belongs to the same "health area" in each province. The investigators also include families' and teachers' knowledge of the context because it can support the interventions of change proposals.

Compassion will be assessed using the Compassion for the Lives of Others Scale (COOLS), comprising 26 items. Similarly, adolescents' attitudes toward death are another important concept and will be explored through the Death Anxiety Scale (DAS), which has 15 questions. Both scales will be distributed to the adolescents, requesting their permission anonymously.

After the survey, a second phase will start with a Participatory Action Research (PAR) with different activities. The objective is to generate awareness of the need to improve it, allowing the participants to design the interventions, based on evidence-based proposals (cinema forum, colloquiums with testimonies of volunteers accompanying palliative patients, organization of Death Cafe, artistic and literary activities, generation of grief groups, etc.).

At the end of the project, the investigators will evaluate the adolescent compassion level and create discussion groups again to understand the impact of the interventions.

With this project, the investigators will empower new generations of people to encourage, facilitate, support, and celebrate mutual care and family and community development in end-of-life processes. The translation and implications of the results for clinical practice will contribute to reducing inequalities in health research in a vulnerable group of special interest, especially when treatments can do nothing for their survival but with interventions such as those in this study, the investigators can ensure quality and dignity of life as long as there is life.

Eligibility

Sex
ALL
Min age
12 Years
Max age
23 Years
Healthy volunteers
Accepted
Inclusion Criteria: * University and high schools that belong to the same "Health Area" * Students enrolled in public secondary schools (12-17 years old) and in different undergraduate studies in a public University (18-23 years old) during the development of the project * Parents, mothers, or legal tutors of minors with communication skills to participate in a group Exclusion Criteria: * Students who need curricular adaptation * Health science studies at the University

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Instituto Murciano de Investigación Biosanitaria Murcia MU

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06310434 on ClinicalTrials.gov ↗ ← All trials in Spain